Cipla Profit
- All
- News
- Videos
-
Cipla's Profit After Tax Up 11% To Rs 789 Crore
Pharmaceutical firm Cipla has announced a 10.9 per cent growth in its profit after tax to Rs 789 crore for the quarter ended September 2022, against Rs 711 crore in the year-ago period.
-
Cipla Q3 Profit Dips 2.6% To Rs 729 Crore
Cipla on Tuesday reported a 2.6 per cent decline in its consolidated profit after tax to Rs 729 crore for the third quarter ended on December 31, 2021
-
Cipla Records Rs 712 Crore Net Profit In September Quarter
The company's EBITDA or earnings before interest, tax, depreciation and amortisation also went up by 4.2 per cent to Rs 1,226.2 crore
-
Cipla Extends Gains For Second Straight Day On Strong June Quarter Earnings
On Friday, the company had reported a net profit of Rs 577.91 crore in the quarter ended June 30, marking a jump of 20.85 per cent compared to the corresponding period a year ago.
-
Cipla Hits Record High After Strong June Quarter Earnings
Cipla Share Price: By 11:22 am, 6.88 lakh Cipla shares had changed hands on the BSE, as against an average of 3.49 lakh over the past two weeks.
-
Cipla June Quarter Profit Jumps 21%
Cipla's revenue from the pharmaceuticals segment rose 7.73 per cent to Rs 4,266.09 crore.
-
Cipla Profit Rises 6% To Rs 478 Crore In June Quarter
Cipla's revenue from its pharmaceuticals business increased 1.22 per cent to Rs 3,959.93 crore in the quarter ended June 30.
-
Sensex, Nifty Move In A Range Amid Cautious Trade
Top laggards on the 50-scrip index were Dr Reddy's, Cipla, Reliance Industries, Coal India and Yes Bank, trading between 1.12 and 2.63 per cent lower.
-
Sensex, Nifty Rebound From Worst Day Of 2019
Top gainers on the 50-scrip index were Zee Entertainment, Bharti Airtel, Cipla and Reliance Industries.
-
Sensex, Nifty Rise Ahead of RBI Policy Statement
The BSE Sensex rose as much as170 points to hit 37,145 in early trade while the NSE Nifty touched 11,101, up 39points from the previous close. Analysts awaited the outcome of the three-day policy review meeting of the Reserve Bank of India's Monetary Policy Committee due later in the day. Top gainers on the 50-scrip index were Sun Pharma, Cipla, HC...
-
Cipla Profit Falls 17% In December Quarter, Misses Analysts' Expectations
Cipla Q3 Report: Cipla, in its last quarterly earnings in November, had warned of headwinds in the second half of the financial year.
-
Sensex Surges Over 150 Points, Nifty Hits 10,700
Gaining between 1.04 per cent and 1.32 per cent, Zee Entertainment, Hero MotoCorp, Infosys, Cipla and Titan were the top five Nifty gainers.
-
Cipla Q2 Net Profit Falls 11%, Misses Street Estimates
The upcoming challenges include capacity balancing in certain categories at plants and sanctions, Cipla said in a post-earnings presentation.
-
Sensex Closes 176 Points Lower, Nifty Gives Up 10,200 Amid Choppy Trade: 10 Things To Know
Stock markets reversed early gains on Tuesday as losses in energy and metal stocks offset strength in IT shares. BSE benchmark index Sensex shed 176 points, or 0.5 per cent, to end at 33,891, while NSE's Nifty settled just shy of 10,200, down 52 points from the previous close. Investors turned cautious a day after key indices rose around 2 per cent...
-
Sensex Closes 224 Points Higher To Break 6-Day Fall, Nifty Reclaims 11,500
Top gainers on the 50-scrip Nifty index included Reliance Industries, Cipla, Coal India, Sun Pharma and Lupin. The Nifty Pharma rose 2.7% led by Aurobindo Pharma, which surged over 9% after the drug maker announced a $900-million acquisition in the US.
-
Cipla's Profit After Tax Up 11% To Rs 789 Crore
Pharmaceutical firm Cipla has announced a 10.9 per cent growth in its profit after tax to Rs 789 crore for the quarter ended September 2022, against Rs 711 crore in the year-ago period.
-
Cipla Q3 Profit Dips 2.6% To Rs 729 Crore
Cipla on Tuesday reported a 2.6 per cent decline in its consolidated profit after tax to Rs 729 crore for the third quarter ended on December 31, 2021
-
Cipla Records Rs 712 Crore Net Profit In September Quarter
The company's EBITDA or earnings before interest, tax, depreciation and amortisation also went up by 4.2 per cent to Rs 1,226.2 crore
-
Cipla Extends Gains For Second Straight Day On Strong June Quarter Earnings
On Friday, the company had reported a net profit of Rs 577.91 crore in the quarter ended June 30, marking a jump of 20.85 per cent compared to the corresponding period a year ago.
-
Cipla Hits Record High After Strong June Quarter Earnings
Cipla Share Price: By 11:22 am, 6.88 lakh Cipla shares had changed hands on the BSE, as against an average of 3.49 lakh over the past two weeks.
-
Cipla June Quarter Profit Jumps 21%
Cipla's revenue from the pharmaceuticals segment rose 7.73 per cent to Rs 4,266.09 crore.
-
Cipla Profit Rises 6% To Rs 478 Crore In June Quarter
Cipla's revenue from its pharmaceuticals business increased 1.22 per cent to Rs 3,959.93 crore in the quarter ended June 30.
-
Sensex, Nifty Move In A Range Amid Cautious Trade
Top laggards on the 50-scrip index were Dr Reddy's, Cipla, Reliance Industries, Coal India and Yes Bank, trading between 1.12 and 2.63 per cent lower.
-
Sensex, Nifty Rebound From Worst Day Of 2019
Top gainers on the 50-scrip index were Zee Entertainment, Bharti Airtel, Cipla and Reliance Industries.
-
Sensex, Nifty Rise Ahead of RBI Policy Statement
The BSE Sensex rose as much as170 points to hit 37,145 in early trade while the NSE Nifty touched 11,101, up 39points from the previous close. Analysts awaited the outcome of the three-day policy review meeting of the Reserve Bank of India's Monetary Policy Committee due later in the day. Top gainers on the 50-scrip index were Sun Pharma, Cipla, HC...
-
Cipla Profit Falls 17% In December Quarter, Misses Analysts' Expectations
Cipla Q3 Report: Cipla, in its last quarterly earnings in November, had warned of headwinds in the second half of the financial year.
-
Sensex Surges Over 150 Points, Nifty Hits 10,700
Gaining between 1.04 per cent and 1.32 per cent, Zee Entertainment, Hero MotoCorp, Infosys, Cipla and Titan were the top five Nifty gainers.
-
Cipla Q2 Net Profit Falls 11%, Misses Street Estimates
The upcoming challenges include capacity balancing in certain categories at plants and sanctions, Cipla said in a post-earnings presentation.
-
Sensex Closes 176 Points Lower, Nifty Gives Up 10,200 Amid Choppy Trade: 10 Things To Know
Stock markets reversed early gains on Tuesday as losses in energy and metal stocks offset strength in IT shares. BSE benchmark index Sensex shed 176 points, or 0.5 per cent, to end at 33,891, while NSE's Nifty settled just shy of 10,200, down 52 points from the previous close. Investors turned cautious a day after key indices rose around 2 per cent...
-
Sensex Closes 224 Points Higher To Break 6-Day Fall, Nifty Reclaims 11,500
Top gainers on the 50-scrip Nifty index included Reliance Industries, Cipla, Coal India, Sun Pharma and Lupin. The Nifty Pharma rose 2.7% led by Aurobindo Pharma, which surged over 9% after the drug maker announced a $900-million acquisition in the US.
